Can gut dysbiosis increase inflammatory signaling and systemic oxidative stress?

The intestinal microbiota plays a crucial role in maintaining systemic physiological balance, and its disruption is closely tied to chronic inflammatory states.

Microbial metabolites and barrier integrity

• Loss of microbial diversity: Gut dysbiosis alters the taxonomic profile of the microbiome, leading to a critical depletion of short-chain fatty acids (SCFAs) like butyrate, alongside elevations in certain primary bile acids.
• Barrier degradation: SCFAs are essential for maintaining the mucosal layer and tight junction proteins, including ZO-1 and occludin. Their depletion compromises barrier integrity, a vulnerability demonstrated in models where transplanting aged or dysbiotic microbiota directly increases intestinal permeability.
• Translocation of triggers: A leaky epithelial barrier allows luminal triggers, such as lipopolysaccharides (LPS) and bacterial fragments, to cross into systemic circulation.

Inflammatory cascades and oxidative stress

• Cytokine activation: The translocation of bacterial components triggers a robust release of pro-inflammatory cytokines, specifically tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β).
• Pathological feed-forward loop: Circulating cytokines (such as TNF-α, IFN-γ, and IL-6) directly downregulate tight junction expression, worsening barrier leakiness. Conversely, specific phenolic metabolites (e.g., benzoic acid and phenylacetic acid) can work synergistically with SCFAs to downregulate inflammatory NF-κB and MAPK pathways.
• Oxidative stress linkage: This persistent state of systemic inflammation is strongly associated with systemic oxidative stress, forming a highly cohesive, pathophysiological loop where chronic cytokine signaling and cellular stress reinforce each other.

Bottom line

• Key takeaway: Gut dysbiosis drives a systemic inflammatory and oxidative state through a self-perpetuating cycle of SCFA depletion, tight junction degradation (ZO-1/occludin), LPS translocation, and cytokine-mediated barrier disruption.